Lu Rahman speaks to George I’ons, head of product strategy and insights at Owen Mumford Pharmaceutical Services about the near-term competitive biosimilars market in the USA and Europe, and its impact on drug delivery device design.
With emerging biotechs playing a critical part in developing new drugs, Merck attempts to understand the interactions between parties when manufacturing monoclonal antibodies (mAbs).
Watson Marlow Fluid Technology Group (WMFTG) speaks to Mark Embury of the American Society of Mechanical Engineers Bioprocessing Equipment (ASME BPE) and valve manufacturer, ASEPCO about the push towards single-use systems in bioprocessing.
Justin Schroeder, vice president for global programme management at PCI Pharma Services, looks at how to support the delivery of biologics through automated inspection systems.
Stéphane Varray - commercial development - head of Launch for Mammalian and Microbial, Development & Manufacturing at Lonza discusses trends in biomanufacturing and the innovation occurring in the sector.
Zak Yusoff, pharmaceutical freeze-drying applications manager at SP Scientific discusses why a quality by design (QbD) approach is key to achieving optimal lyophilisation of limited and expensive biopharmaceutical drugs.
EPM editor Reece Armstrong sits down with Andrew Bulpin - head of process solutions at the life science business of Merck - to discuss the industry and the company’s new platform for ‘contiGuous’ manufacturing in bioprocessing.
Dr Andrew Naylor, research and development director, Upperton Pharma Solutions, explains why spray drying might be the preferred method for biotherapeutics.
Jonathan Wilkins, marketing director of obsolete industrial parts supplier EU Automation, explains how biopharmaceutical plants can benefit from automation.
David Staunton, global director services at Zenith Technologies and Scott Ripley, global marketing director at GE Healthcare, discuss the benefits of single-use technology and how patients are the ultimate beneficiaries.
Charlie Johnson, CEO of biotechnology company ADC Bio, explains how substantial cost savings and faster time to market is achievable through the novel concept of combining the bioconjugation and purification steps.
